Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans A Grifoni, J Pham, J Sidney, PH O'Rourke, S Paul, B Peters, SR Martini, ... Journal of virology 91 (24), 10.1128/jvi. 01469-17, 2017 | 185 | 2017 |
Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas A Grifoni, MA Angelo, B Lopez, PH O’Rourke, J Sidney, C Cerpas, ... Frontiers in immunology 8, 1309, 2017 | 82 | 2017 |
Predictors of mortality in patients with yellow fever: an observational cohort study EG Kallas, LGFABDE Zanella, CHV Moreira, R Buccheri, GBF Diniz, ... The Lancet infectious diseases 19 (7), 750-758, 2019 | 77 | 2019 |
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial EG Kallas, AR Precioso, R Palacios, B Thomé, PE Braga, T Vanni, ... The Lancet Infectious Diseases 20 (7), 839-850, 2020 | 61 | 2020 |
MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection D Paquin-Proulx, VI Avelino-Silva, BAN Santos, N Silveira Barsotti, ... PLoS neglected tropical diseases 12 (1), e0006154, 2018 | 49 | 2018 |
Aspectos do escorpionismo no Estado do Pará-Brasil A Maestri Neto, AB Guedes, SF Carmo, HM Chalkidis, J Souza Coelho, ... Revista Paraense de Medicina 22 (1), 49-55, 2008 | 26 | 2008 |
A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus DM Magnani, CGT Silveira, BC Rosen, MJ Ricciardi, N Pedreño-Lopez, ... PLoS neglected tropical diseases 11 (6), e0005655, 2017 | 20 | 2017 |
T-cell responses in individuals infected with Zika virus and in those vaccinated against dengue virus D Paquin-Proulx, FE Leal, CGT Silveira, A Maestri, C Brockmeyer, ... Pathogens & immunity 2 (2), 274, 2017 | 20 | 2017 |
Persistence of rabies virus-neutralizing antibodies after vaccination of rural population following vampire bat rabies outbreak in Brazil R Medeiros, V Jusot, G Houillon, A Rasuli, L Martorelli, AP Kataoka, ... PLoS Neglected Tropical Diseases 10 (9), e0004920, 2016 | 19 | 2016 |
Siaα2-3Galβ1- Receptor Genetic Variants Are Associated with Influenza A(H1N1)pdm09 Severity A Maestri, VA Sortica, L Tovo-Rodrigues, MC Santos, L Barbagelata, ... PloS one 10 (10), e0139681, 2015 | 18 | 2015 |
Robust and functional immune memory up to 9 months after SARS-CoV-2 infection: a Southeast Asian longitudinal cohort HTM Vo, A Maestri, H Auerswald, S Sorn, S Lay, H Seng, S Sann, N Ya, ... Frontiers in Immunology 13, 817905, 2022 | 17 | 2022 |
The CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population A Maestri, MC Dos Santos, EM Ribeiro-Rodrigues, WA De Mello, ... BMC research notes 8, 1-5, 2015 | 17 | 2015 |
Dissecting drivers of immune activation in chronic HIV-1 infection H Streeck, A Maestri, D Habermann, TA Crowell, AL Esber, G Son, ... Ebiomedicine 83, 2022 | 9 | 2022 |
Neurological manifestations in people living with HIV/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in São Paulo, Brazil JP Telles, R Fernandes, TD Barros, A Maestri, T Vitoriano, L Borges, ... HIV Research & Clinical Practice 22 (4), 87-95, 2021 | 9 | 2021 |
Global assessment of dengue virus-specific CD4 (+) T cell responses in dengue-endemic areas. Front Immunol 8: 1309 A Grifoni, MA Angelo, B Lopez, PH O’Rourke, J Sidney, C Cerpas, ... | 7 | 2017 |
Viral kinetics in sylvatic yellow fever cases VI Avelino-Silva, MV Thomazella, MP Marmorato, CA Correia, JZC Dias, ... The Journal of Infectious Diseases 227 (9), 1097-1103, 2023 | 5 | 2023 |
The His131Arg substitution in the FCGR2A gene (rs1801274) is not associated with the severity of influenza A (H1N1) pdm09 infection A Maestri, VA Sortica, DL Ferreira, J de Almeida Ferreira, MAT Amador, ... BMC Research Notes 9, 1-4, 2016 | 5 | 2016 |
Levels of angiopoietin-2 are predictive for mortality in yellow fever virus infected patients. CAM van de Weg, MV Thomazella, MP Marmorato, CA Correia, JZC Dias, ... The Journal of Infectious Diseases, jiad389-jiad389, 2023 | 1 | 2023 |
A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+ 1 regimen in … A Maestri, SE Park, F Fernandes, ZL Li, YJ Kim, YK Kim, J Lee, JY Park, ... Human Vaccines & Immunotherapeutics 20 (1), 2321035, 2024 | | 2024 |
Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients ANA Goncalves, PR Costa, MV Thomazella, CA Correia, MP Marmorato, ... medRxiv, 2024.05. 04.24306661, 2024 | | 2024 |